Literature DB >> 8613144

Genetic variability of the human CD4 V2 domain.

S Indraccolo1, M Mion, R Biagiotti, S Romagnani, M Morfini, G Longo, R Zamarchi, L Chieco-Bianchi, A Amadori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8613144     DOI： 10.1007/bf02602658

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  22 in total

1.  Characterization of a polymorphism of CD4 in miniature swine.

Authors:  T M Sundt; C LeGuern; S Germana; C V Smith; K Nakajima; J K Lunney; D H Sachs
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

2.  Infection of T4 lymphocytes by HTLV-III does not require expression of the OKT4 epitope.

Authors:  J A Hoxie; L E Flaherty; B S Haggarty; J L Rackowski
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  A single amino acid substitution in a common African allele of the CD4 molecule ablates binding of the monoclonal antibody, OKT4.

Authors:  S Lederman; J A DeMartino; B L Daugherty; I Foeldvari; M J Yellin; A M Cleary; N Berkowitz; I Lowy; N S Braunstein; G E Mark
Journal:  Mol Immunol       Date:  1991-11       Impact factor: 4.407

4.  Identification of the residues in human CD4 critical for the binding of HIV.

Authors:  J Arthos; K C Deen; M A Chaikin; J A Fornwald; G Sathe; Q J Sattentau; P R Clapham; R A Weiss; J S McDougal; C Pietropaolo
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

5.  Genetic control of the CD4/CD8 T-cell ratio in humans.

Authors:  A Amadori; R Zamarchi; G De Silvestro; G Forza; G Cavatton; G A Danieli; M Clementi; L Chieco-Bianchi
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

6.  A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development.

Authors:  S Sawada; J D Scarborough; N Killeen; D R Littman
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

7.  Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group.

Authors:  J Hassett; G F Gjerset; J W Mosley; M A Fletcher; E Donegan; J W Parker; R B Counts; L M Aledort; H Lee; M C Pike
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

8.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

9.  A CD3+CD8+ T cell population lacking CD5 antigen expression is expanded in peripheral blood of human immunodeficiency virus-infected patients.

Authors:  S Indraccolo; M Mion; R Zamarchi; V Coppola; F Calderazzo; A Amadori; L Chieco-Bianchi
Journal:  Clin Immunol Immunopathol       Date:  1995-12

10.  The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: in vivo and in vitro correlations.

Authors:  P Nara; W Hatch; J Kessler; J Kelliher; S Carter
Journal:  J Med Primatol       Date:  1989       Impact factor: 0.667
View more
  1 in total

1.  The CD4 C868T Polymorphism and Its Correlation with HIV-1 Infection in a Chinese Population.

Authors:  Yu Lu; Junrong Wu; Xue Qin; Li Xie; Liping Ma; Xiuli Huang; Jiangyang Zhao; Yanqiong Liu; Xuejie Chen; Shan Li
Journal:  AIDS Res Hum Retroviruses       Date:  2015-03-06       Impact factor: 2.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.